Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
From 1995 to 2016, hepatocellular carcinoma incidence in rural populations climbed by 218%.
People who received a higher dose had stronger and longer-lasting immune responses.
Barriers still stand in the way of making treatment available to all who need it.
Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
The early cancer is detected, the easier it is to treat.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
This is a good time to talk about how sleep can affect the body’s immune response to a vaccination.
Unexpectedly, liver steatosis was also associated with a greater chance of achieving HBsAg seroclearance.
But experts suggest that a move toward universal hepatitis B screening and vaccination may be in order.
Blue Faery’s “Love Your Liver” 28-day video campaign raises awareness of liver cancer and overall liver health.
Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.
Areas with lower population density have not seen the same slowdown as urban areas.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
People who switched showed improvement in markers of kidney and bone health but also rise in lipid levels.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.